DE69313114T2 - NEUE DELTA-17 UND DELTA-20 UNGESÄTIGTE UND GESATIGTE 17--g(b)-SUBSTITUIERTE-4-AZA-5-g(a)-ANDROSTAN-3-ON VERBINDUNGEN ALS INHIBITOREN VON 5-ALPHA-REDUCTASE - Google Patents

NEUE DELTA-17 UND DELTA-20 UNGESÄTIGTE UND GESATIGTE 17--g(b)-SUBSTITUIERTE-4-AZA-5-g(a)-ANDROSTAN-3-ON VERBINDUNGEN ALS INHIBITOREN VON 5-ALPHA-REDUCTASE

Info

Publication number
DE69313114T2
DE69313114T2 DE69313114T DE69313114T DE69313114T2 DE 69313114 T2 DE69313114 T2 DE 69313114T2 DE 69313114 T DE69313114 T DE 69313114T DE 69313114 T DE69313114 T DE 69313114T DE 69313114 T2 DE69313114 T2 DE 69313114T2
Authority
DE
Germany
Prior art keywords
aza
methyl
pregn
phenyl
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69313114T
Other languages
German (de)
English (en)
Other versions
DE69313114D1 (de
Inventor
Susan Aster
Donald Graham
Richard Tolman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69313114D1 publication Critical patent/DE69313114D1/de
Application granted granted Critical
Publication of DE69313114T2 publication Critical patent/DE69313114T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE69313114T 1992-05-20 1993-05-17 NEUE DELTA-17 UND DELTA-20 UNGESÄTIGTE UND GESATIGTE 17--g(b)-SUBSTITUIERTE-4-AZA-5-g(a)-ANDROSTAN-3-ON VERBINDUNGEN ALS INHIBITOREN VON 5-ALPHA-REDUCTASE Expired - Fee Related DE69313114T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88605092A 1992-05-20 1992-05-20
PCT/US1993/004630 WO1993023050A1 (en) 1992-05-20 1993-05-17 NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS

Publications (2)

Publication Number Publication Date
DE69313114D1 DE69313114D1 (de) 1997-09-18
DE69313114T2 true DE69313114T2 (de) 1998-03-19

Family

ID=25388271

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69313114T Expired - Fee Related DE69313114T2 (de) 1992-05-20 1993-05-17 NEUE DELTA-17 UND DELTA-20 UNGESÄTIGTE UND GESATIGTE 17--g(b)-SUBSTITUIERTE-4-AZA-5-g(a)-ANDROSTAN-3-ON VERBINDUNGEN ALS INHIBITOREN VON 5-ALPHA-REDUCTASE

Country Status (8)

Country Link
US (2) US5510351A (enExample)
EP (1) EP0646007B1 (enExample)
JP (1) JPH07508032A (enExample)
AT (1) ATE156839T1 (enExample)
AU (1) AU676478B2 (enExample)
CA (1) CA2135056A1 (enExample)
DE (1) DE69313114T2 (enExample)
WO (1) WO1993023050A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0646007B1 (en) * 1992-05-20 1997-08-13 Merck & Co. Inc. NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONES AS 5$g(a)-REDUCTASE INHIBITORS
US5710275A (en) * 1992-05-20 1998-01-20 Merck & Co., Inc. 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
US5470976A (en) * 1994-09-07 1995-11-28 Merck & Co., Inc. Process for the stereoselective reduction of steroid enelactams
US5817818A (en) * 1994-09-16 1998-10-06 Glaxo Wellcome Inc. Androstenones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5656613A (en) * 1995-01-04 1997-08-12 Merck & Co., Inc. Treatment of hyperandrogenic conditions
US5886005A (en) * 1995-01-17 1999-03-23 Merck & Co., Inc. 4-Aza-19-norandrostane derivatives
US5872126A (en) * 1996-09-06 1999-02-16 Merck & Co., Inc. Methods and compositions for treating preterm labor
US5998427A (en) * 1998-05-14 1999-12-07 Glaxo Wellcome Inc. Androstenones
WO2002092799A2 (en) * 2001-05-11 2002-11-21 Bayer Aktiengesellschaft Regulation of human steroid 5-alpha reductase-like protein
US7482357B2 (en) 2003-06-30 2009-01-27 Merck & Co., Inc. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
AU2004259664B2 (en) * 2003-06-30 2009-05-28 Merck Sharp & Dohme Corp. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
CA2530048A1 (en) * 2003-06-30 2005-01-20 Merck & Co., Inc. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
WO2005005380A2 (en) * 2003-06-30 2005-01-20 Merck & Co., Inc. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
JP2007505118A (ja) 2003-09-10 2007-03-08 メルク　エンド　カムパニー　インコーポレーテッド アンドロゲン受容体調節剤としての１７−複素環−４−アザステロイド誘導体
CA2537660A1 (en) * 2003-09-10 2005-03-24 Merck & Co., Inc. 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
WO2005044988A2 (en) * 2003-10-31 2005-05-19 Merck & Co., Inc. 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
CN1942187A (zh) * 2004-04-08 2007-04-04 默克公司 作为雄激素受体调节剂的17β－乙酰胺－4－氮杂甾体化合物
AU2009320250A1 (en) * 2008-10-28 2010-06-03 Biomarin Pharmaceutical Inc. Decahydro-1H-indenoquinolinone and decahydro-3H-cyclopentaphenanthridinone CYP17 inhibitors

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1465544A (fr) * 1965-11-29 1967-01-13 Roussel Uclaf Dérivés stéroïdes aromatiques substitués par un atome d'azote endocyclique et procédé de préparation
US4596812A (en) * 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
AU527030B2 (en) * 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4220775A (en) * 1979-03-15 1980-09-02 Merck & Co., Inc. Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors
US4337584A (en) * 1980-09-05 1982-07-06 Johnson Lawrence D Heat pump grain dryer
US4690175A (en) * 1981-11-17 1987-09-01 Kabushiki Kaisha Medos Kenkyusho Flexible tube for endoscope
US4859681A (en) * 1984-02-27 1989-08-22 Merck & Co., Inc. 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US5120742A (en) * 1984-02-27 1992-06-09 Merck & Co., Inc. 17 β-acyl-4-aza-5 α-androst-1-ene-3-ones as 5 α-reductase inhibitors
US5049562A (en) * 1984-02-27 1991-09-17 Merck & Co., Inc. 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
US4775371A (en) * 1986-09-02 1988-10-04 Advanced Cardiovascular Systems, Inc. Stiffened dilatation catheter and method of manufacture
US4888336A (en) * 1987-01-28 1989-12-19 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5110939A (en) * 1987-01-28 1992-05-05 Smithkline Beecham Corporation Intermediates in the preparation of steriod 5-alpha-reductase inhibitors
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5116983A (en) * 1988-04-18 1992-05-26 Merck & Co., Inc. Dehydrogenation process intermediates
US5084574A (en) * 1988-04-18 1992-01-28 Merck & Co., Inc. Dehydrogenation process
US4882319A (en) * 1988-12-23 1989-11-21 Smithkline Beckman Corporation Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase
US5175155A (en) * 1991-10-07 1992-12-29 Sterling Winthrop Inc. Win 49596-finasteride method of use and compositions
US5710275A (en) * 1992-05-20 1998-01-20 Merck & Co., Inc. 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors
EP0646007B1 (en) * 1992-05-20 1997-08-13 Merck & Co. Inc. NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONES AS 5$g(a)-REDUCTASE INHIBITORS
EP0641209A4 (en) * 1992-05-20 1995-08-23 Merck & Co Inc NEW 17-ESTER, AMID AND KETONE DERIVATIVES OF 3-OXO-4-AZASTEROIDS AS 5-ALPHA REDUCTINE INHIBITORS.
WO1993023039A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors
GB9213835D0 (en) * 1992-06-30 1992-08-12 Smithkline Beecham Corp Compounds
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use

Also Published As

Publication number Publication date
CA2135056A1 (en) 1993-11-25
AU676478B2 (en) 1997-03-13
WO1993023050A1 (en) 1993-11-25
JPH07508032A (ja) 1995-09-07
US5510351A (en) 1996-04-23
EP0646007B1 (en) 1997-08-13
DE69313114D1 (de) 1997-09-18
US5760045A (en) 1998-06-02
AU4250493A (en) 1993-12-13
EP0646007A1 (en) 1995-04-05
ATE156839T1 (de) 1997-08-15
EP0646007A4 (enExample) 1995-04-26

Similar Documents

Publication Publication Date Title
DE69313114T2 (de) NEUE DELTA-17 UND DELTA-20 UNGESÄTIGTE UND GESATIGTE 17--g(b)-SUBSTITUIERTE-4-AZA-5-g(a)-ANDROSTAN-3-ON VERBINDUNGEN ALS INHIBITOREN VON 5-ALPHA-REDUCTASE
DE69313018T2 (de) Neue 7-Beta-substituierte-4-Aza-5-Alpha-Androstan-3-Onen als Inhibitoren 5-Alpha-Reduktases
US4377584A (en) 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
DE69314769T2 (de) 17-beta-substituierte 4-aza-5-alpha-androstan-3-on derivate
DE69313921T2 (de) Neue 7-Beta-substituierte-4-Aza-5-Alpha-Cholestan-Onen als Inhibitoren 5-Alpha-Reduktases
US5510485A (en) 17-ester, amide, and ketone derivatives of 3-oxo-4-azasteroids as 5A-reductase inhibitors
US5595996A (en) 7-substituted 4-aza cholanic acid derivatives and their use
DE69413393T2 (de) In 15-stellung substituierte 4-azasteroide
SK140494A3 (en) Inhibitors of testosterone 5-alpha-reductase activity
CZ122896A3 (en) 16-substituted 4-azaandrostane derivatives and pharmaceutical compositions containing thereof
EP0465141A2 (en) N-monosubstituted adamantyl/norbornanyl 17beta-carbamides of3-carboxy-androst-3,5-dienes
DE69327537T2 (de) 17-beta-arylester carboxylate von 4-aza-5-alpha-androstan-3-one
US5525608A (en) 17b-aryl-4-aza-steroid derivatives useful as 5-alpha-reductase inhibitors
DE69119992T2 (de) 4-Amino-delta4-Steroide und ihre Verwendung als Inhibitoren von 5alpha-Reduktase
DE69119502T2 (de) 4-Amino-delta4,6-Steroide und ihre Verwendung als Inhibitoren von 5alpha-Reduktase
CA2136303A1 (en) Improved antiandrogens
EP0528485A1 (en) 17Beta-acyl-3-androsta-3,5-dienes as testosterone 5alpha-reductase inhibitors
DE69405760T2 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
DE69422629T2 (de) Indolderivate als 5-alpha-reductase-1 inhibitoren
WO1995013077A1 (en) 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-3-ONES AS SELECTIVE 5α-REDUCTASE 1 INHIBITORS
CA2045866A1 (en) 17-beta-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5 alpha-reductase inhibitors
WO1995013815A1 (en) Combination method for the treatment of patterned alopecia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee